QuidelOrtho Signs Strategic Supply Agreement With Lifotronic Technology

Reuters02-16 14:00

QuidelOrtho Signs Strategic Supply Agreement With Lifotronic Technology

QuidelOrtho Corporation has announced a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. The agreement is intended to expand QuidelOrtho's global immunoassay portfolio and accelerate access to high quality, cost-efficient solutions in selected markets outside the United States. The collaboration provides QuidelOrtho with access to multiple immunoassay analyzer platforms and a broad menu of over 70 assays, including more than 25 new assays not currently available on QuidelOrtho's VITROS system. The expanded offering is aimed at increasing QuidelOrtho's competitiveness in international tenders and serving a wider range of laboratory settings across regions such as Europe, the Middle East, Africa, Mexico, Central and South America, India, China, Japan, and Asia-Pacific.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quidelortho Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602160100PR_NEWS_EURO_ND__EN88356) on February 16, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2611105298?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-16 14:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2611105298","market":"nz","top_or_hot":-1,"title":"QuidelOrtho Signs Strategic Supply Agreement With Lifotronic Technology","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      QuidelOrtho Signs Strategic Supply Agreement With Lifotronic Technology\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        QuidelOrtho Corporation has announced a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. The agreement is intended to expand QuidelOrtho's global immunoassay portfolio and accelerate access to high quality, cost-efficient solutions in selected markets outside the United States. The collaboration provides QuidelOrtho with access to multiple immunoassay analyzer platforms and a broad menu of over 70 assays, including more than 25 new assays not currently available on QuidelOrtho's VITROS system. The expanded offering is aimed at increasing QuidelOrtho's competitiveness in international tenders and serving a wider range of laboratory settings across regions such as Europe, the Middle East, Africa, Mexico, Central and South America, India, China, Japan, and Asia-Pacific.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quidelortho Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602160100PR_NEWS_EURO_ND__EN88356) on February 16, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QuidelOrtho Signs Strategic Supply Agreement With Lifotronic Technology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuidelOrtho Signs Strategic Supply Agreement With Lifotronic Technology\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-16 14:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      QuidelOrtho Signs Strategic Supply Agreement With Lifotronic Technology\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        QuidelOrtho Corporation has announced a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. The agreement is intended to expand QuidelOrtho's global immunoassay portfolio and accelerate access to high quality, cost-efficient solutions in selected markets outside the United States. The collaboration provides QuidelOrtho with access to multiple immunoassay analyzer platforms and a broad menu of over 70 assays, including more than 25 new assays not currently available on QuidelOrtho's VITROS system. The expanded offering is aimed at increasing QuidelOrtho's competitiveness in international tenders and serving a wider range of laboratory settings across regions such as Europe, the Middle East, Africa, Mexico, Central and South America, India, China, Japan, and Asia-Pacific.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quidelortho Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602160100PR_NEWS_EURO_ND__EN88356) on February 16, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nNDL2fhPwl:1","article_id":"2611105298","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2611105298","pubTimestamp":1771221651,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"QuidelOrtho Corporation has announced a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. The agreement is intended to expand QuidelOrtho's global immunoassay portfolio and accelerate access to high quality, cost-efficient solutions in selected markets outside the United States. The collaboration provides QuidelOrtho with access to multiple immunoassay analyzer platforms and a broad menu of over 70 assays, including more than 25 new assays not currently available on QuidelOrtho's VITROS system. The expanded offering is aimed at increasing QuidelOrtho's competitiveness in international tenders and serving a wider range of laboratory settings across regions such as Europe, the Middle East, Africa, Mexico, Central and South America, India, China, Japan, and Asia-Pacific.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","QDEL":"窥得儿医药","BK4198":"医疗保健用品"},"translate_title":"QuidelOrtho与Lifotronic Technology签署战略供应协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"QDEL":0.9},"content_text":"QuidelOrtho Signs Strategic Supply Agreement With Lifotronic Technology\n    \n\n        QuidelOrtho Corporation has announced a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. The agreement is intended to expand QuidelOrtho's global immunoassay portfolio and accelerate access to high quality, cost-efficient solutions in selected markets outside the United States. The collaboration provides QuidelOrtho with access to multiple immunoassay analyzer platforms and a broad menu of over 70 assays, including more than 25 new assays not currently available on QuidelOrtho's VITROS system. The expanded offering is aimed at increasing QuidelOrtho's competitiveness in international tenders and serving a wider range of laboratory settings across regions such as Europe, the Middle East, Africa, Mexico, Central and South America, India, China, Japan, and Asia-Pacific.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quidelortho Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602160100PR_NEWS_EURO_ND__EN88356) on February 16, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2611105298","isCrawlerRequest":true}